The GE-Geron deal demonstrates that well-capitalized companies see the huge potential in stem cell research and development. If companies like GE see the potential for stem cell technology to bring new and amazing drugs to market, then it's probably safe to say that investors are going to start searching for the long-term stem cell winners.
With that in mind, let's take a look at a few stem cell stock charts that could be setting up to make a big move. To read more, visit Stockpickr.com.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,475.51 | 1,110.97 | 2,191.37 | 33.12 |
Oil *
78.54
|
|
UP
3.93
|
UP
2.11
|
UP
15.56
|
UP
0.37
|
10 Yr
3.31%
SPDR Gold
118.98
|
|
+0.04%
|
+0.19%
|
+0.72%
|
+1.13%
|
Data delayed 20 minutes |
